Dynavax Technologies | Capital Ordinário



Ordinary Share Capital Alterar Data
AbbVie USD 18M 0 2024-12
Adma Biologics USD 24K 0 2024-12
Amgen USD 33.58B 45M 2025-03
AstraZeneca USD 388M 0 2025-03
Biogen USD 100K 0 2025-03
BioMarin Pharmaceutical USD 192K 1000 2025-03
Bristol-Myers Squibb USD 292M 0 2025-03
Dynavax Technologies USD 124K 1000 2025-03
Gilead Sciences USD 1000K 0 2024-12
Glaxosmithkline GBP 1.35B 0 2024-12
Merck USD 1.79B 0 2025-03
Neurocrine Biosciences USD 100K 0 2024-12
Novartis USD 793M 0 2024-12
Pfizer USD 481M 1000K 2025-03
Regeneron Pharmaceuticals USD 0 102K 2025-03
Roche Holding CHF 107M 0 2024-06
Sarepta Therapeutics USD 10K 0 2025-03
TG Therapeutics USD 156K 0 2024-12
Vertex Pharmaceuticals USD 2.6M 0 2024-12



Dynavax Technologies Capital Ordinário - Valores atuais, dados históricos, previsões, estatísticas, gráficos e calendário econômico - May 2025.